{"transactions":[{"id":909484,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2026-02-12T02:03:07.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":273750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to 25% of the shares on February 8, 2027, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2030."}],"balance_after":273750,"derivative":{"exercise_price":12.75,"expiration_date":"2036-02-05","underlying":"Ordinary Shares","underlying_shares":273750},"source":{"system":"sec-edgar","filing":"0001193125-26-047323","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526047323/ownership.xml","form_type":"4"}},{"id":909483,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-12T02:03:07.000Z","date":"2026-02-09","kind":"sale","planned":false,"acquired":false,"shares":3588,"price":13.45,"value":48258.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On February 9, 2026, the reporting person sold 3,588 ordinary shares solely to cover taxes associated with the vesting of restricted share units (\"RSUs\") on February 8, 2026. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations."}],"balance_after":134385,"source":{"system":"sec-edgar","filing":"0001193125-26-047323","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526047323/ownership.xml","form_type":"4"}},{"id":909482,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-02-12T02:03:07.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":45625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2027 through February 8, 2030."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,983 ordinary shares acquired on January 14, 2026, under the issuer's 2019 Employee Share Purchase Plan."}],"balance_after":137973,"source":{"system":"sec-edgar","filing":"0001193125-26-047323","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312526047323/ownership.xml","form_type":"4"}},{"id":973981,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-09","kind":"grant","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.48,"expiration_date":"2031-02-01","underlying":"Ordinary Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973980,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-09","kind":"grant","planned":true,"acquired":false,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":8.17,"expiration_date":"2030-03-03","underlying":"Ordinary Shares","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973979,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-08","kind":"grant","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The share option represented a right to purchase a total of 272,200 ordinary shares that vest as to 25% of the shares on February 17, 2024 and vests as to an additional 6.25% of the shares quarterly thereafter until February 17, 2027."}],"balance_after":222700,"derivative":{"exercise_price":4.75,"expiration_date":"2033-02-17","underlying":"Ordinary Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973978,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-08","kind":"grant","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The share option represented a right to purchase a total of 175,000 ordinary shares that vest as to 25% of the shares on January 1, 2023 and vests as to an additional 6.25% of the shares quarterly thereafter until January 1, 2026."}],"balance_after":75000,"derivative":{"exercise_price":3.14,"expiration_date":"2032-01-01","underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973977,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-08","kind":"grant","planned":true,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These share options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.83,"expiration_date":"2032-07-25","underlying":"Ordinary Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973976,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":20.025,"value":1001250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $20.00 to $20.22 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 1,147 ordinary shares acquired on July 14, 2025, under the issuer's 2019 Employee Share Purchase Plan."}],"balance_after":90365,"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973975,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":10.48,"value":524000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":139218,"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973974,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-09","kind":"sale","planned":true,"acquired":false,"shares":36,"price":20.25,"value":729.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $20.00 to $20.22 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":89218,"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973973,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-09","kind":"exercise","planned":true,"acquired":true,"shares":36000,"price":8.17,"value":294120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":125218,"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973972,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":18,"value":900000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":89218,"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973971,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":4.75,"value":237500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":139218,"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973970,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":13.2,"value":660000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":89218,"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973969,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":15,"value":750000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $15.00 to $15.045 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":139218,"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973968,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":3.14,"value":314000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":189218,"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973967,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":60000,"price":13.2,"value":792000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":89218,"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":973966,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-12-11T02:45:05.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":60000,"price":2.83,"value":169800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025."}],"balance_after":149218,"source":{"system":"sec-edgar","filing":"0001193125-25-314736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000119312525314736/ownership.xml","form_type":"4"}},{"id":1280006,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2025-02-07T01:00:09.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":252000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 25% of the shares on February 8, 2026, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2029."}],"balance_after":252000,"derivative":{"exercise_price":11.74,"expiration_date":"2035-02-04","underlying":"Ordinary Shares","underlying_shares":252000},"source":{"system":"sec-edgar","filing":"0000950170-25-015682","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017025015682/ownership.xml","form_type":"4"}},{"id":1280005,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2025-02-07T01:00:09.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2026 through February 8, 2029."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,441 ordinary shares acquired on January 14, 2025, under the issuer's 2019 Employee Share Purchase Plan."}],"balance_after":89218,"source":{"system":"sec-edgar","filing":"0000950170-25-015682","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017025015682/ownership.xml","form_type":"4"}},{"id":1387444,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2024-10-12T00:00:04.000Z","date":"2024-10-11","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The share options that were exercised via cash purchase in this reportable transaction were fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-24-114422","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017024114422/ownership.xml","form_type":"4"}},{"id":1387443,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-10-12T00:00:04.000Z","date":"2024-10-11","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":2.48,"value":62000.0,"ownership":{"direct":true},"balance_after":44777,"source":{"system":"sec-edgar","filing":"0000950170-24-114422","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017024114422/ownership.xml","form_type":"4"}},{"id":1398343,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-09-28T00:00:03.000Z","date":"2024-09-25","kind":"sale","planned":true,"acquired":false,"shares":17146,"price":9,"value":154314.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,002 ordinary shares acquired on July 14, 2024, under the issuer's 2019 Employee Share Purchase Plan."}],"balance_after":19777,"source":{"system":"sec-edgar","filing":"0000950170-24-110141","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017024110141/ownership.xml","form_type":"4"}},{"id":1546420,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2024-04-06T00:00:06.000Z","date":"2024-04-03","kind":"sale","planned":true,"acquired":false,"shares":15630,"price":6.169,"value":96421.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $6.115 to $6.23 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,431 ordinary shares acquired on January 14, 2024, under the issuer's 2019 Employee Share Purchase Plan."}],"balance_after":33921,"source":{"system":"sec-edgar","filing":"0000950170-24-042381","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017024042381/ownership.xml","form_type":"4"}},{"id":1654931,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2024-02-08T00:05:11.000Z","date":"2024-02-05","kind":"grant","planned":false,"acquired":true,"shares":371500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the shares on February 5, 2025, and vests as to an additional 6.25% of the shares quarterly thereafter until February 5, 2028."}],"balance_after":371500,"derivative":{"exercise_price":3.87,"expiration_date":"2034-02-05","underlying":"Ordinary Shares","underlying_shares":371500},"source":{"system":"sec-edgar","filing":"0000950170-24-012394","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000095017024012394/ownership.xml","form_type":"4"}},{"id":1798355,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-08-24T01:15:28.000Z","date":"2023-08-23","kind":"sale","planned":true,"acquired":false,"shares":37062,"price":4.752,"value":176118.624,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 10, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $4.75 to $4.76 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,431 ordinary shares acquired on July 14, 2023, under the issuer's 2019 Employee Share Purchase Plan."}],"balance_after":46120,"source":{"system":"sec-edgar","filing":"0000899243-23-018361","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924323018361/doc4.xml","form_type":"4"}},{"id":2006440,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2023-02-18T01:00:12.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":272700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to 25% of the shares on February 17, 2024 and vests as to an additional 6.25% of the shares quarterly thereafter until February 17, 2027."}],"balance_after":272700,"derivative":{"exercise_price":4.75,"expiration_date":"2033-02-17","underlying":"Ordinary Shares","underlying_shares":272700},"source":{"system":"sec-edgar","filing":"0000899243-23-005562","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924323005562/doc4.xml","form_type":"4"}},{"id":2006439,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2023-02-18T01:00:12.000Z","date":"2023-02-16","kind":"sale","acquired":false,"shares":9729,"price":4.04,"value":39305.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 16, 2023, the reporting person sold 9,729 ordinary shares solely to cover taxes associated with the vesting of restricted share units (\"RSUs\") on February 15, 2023. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $4.03 to $4.18 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,500 ordinary shares acquired on July 14, 2022, and 3,413 ordinary shares acquired on January 14, 2023, under the issuer's 2019 Employee Share Purchase Plan."}],"balance_after":79751,"source":{"system":"sec-edgar","filing":"0000899243-23-005562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924323005562/doc4.xml","form_type":"4"}},{"id":2201249,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2022-07-28T01:20:15.000Z","date":"2022-07-25","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 50% of the shares on July 25, 2023 and 50% on July 25, 2024."}],"balance_after":60000,"derivative":{"exercise_price":2.83,"expiration_date":"2032-07-25","underlying":"Ordinary Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-22-026928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924322026928/doc4.xml","form_type":"4"}},{"id":2278964,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-05-06T23:10:10.000Z","date":"2022-05-05","kind":"sale","acquired":false,"shares":5021,"price":1.72,"value":8636.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On May 5, 2022, the reporting person sold 5,021 ordinary shares solely to cover taxes associated with the vesting of the PSUs on May 4, 2022. These sales were made pursuant to a provision in the reporting person's PSU agreement that requires automatic sales of shares to cover tax withholding obligations. The sales are intended to comply with Rule 10b5-1(c)(1)(i)(B) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $1.72 to $1.741 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":84567,"source":{"system":"sec-edgar","filing":"0000899243-22-017133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924322017133/doc4.xml","form_type":"4"}},{"id":2278963,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-05-06T23:10:10.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 7, 2019, the reporting person received performance-based restricted share units (\"PSUs\"), convertible on a one-for-one basis into ordinary shares of the issuer upon vesting. On May 4, 2022, 50% of the PSUs vested upon the issuer's achievement of the PN Chemistry Milestone (as defined in the PSU agreement) following the issuer's recent WVE-004 data release, as certified by the issuer's compensation committee."}],"balance_after":89588,"source":{"system":"sec-edgar","filing":"0000899243-22-017133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924322017133/doc4.xml","form_type":"4"}},{"id":2384724,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2022-02-18T23:20:15.000Z","date":"2022-02-16","kind":"sale","acquired":false,"shares":9204,"price":2.31,"value":21261.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 16, 2022, the reporting person sold 9,204 ordinary shares solely to cover taxes associated with the vesting of restricted share units (\"RSUs\") on February 15, 2022. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $2.31 to $2.38 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,500 ordinary shares acquired on July 14, 2021, and 1,500 ordinary shares acquired on January 14, 2022, under the issuer's 2019 Employee Share Purchase Plan (ESPP)."}],"balance_after":74588,"source":{"system":"sec-edgar","filing":"0000899243-22-007066","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924322007066/doc4.xml","form_type":"4"}},{"id":2447259,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2022-01-05T02:19:12.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the shares on January 1, 2023 and vests as to an additional 6.25% of the shares quarterly thereafter until January 1, 2026."}],"balance_after":175000,"derivative":{"exercise_price":3.14,"expiration_date":"2032-01-01","underlying":"Ordinary Shares","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0000899243-22-000670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924322000670/doc4.xml","form_type":"4"}},{"id":2772803,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2021-03-24T23:45:07.000Z","date":"2021-03-24","kind":"exercise","acquired":false,"shares":10930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The share options that were exercised in this reportable transaction are fully vested."}],"balance_after":25000,"derivative":{"exercise_price":2.48,"expiration_date":"2025-03-10","underlying":"Ordinary Shares","underlying_shares":10930},"source":{"system":"sec-edgar","filing":"0000899243-21-013331","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924321013331/doc4.xml","form_type":"4"}},{"id":2772802,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-03-24T23:45:07.000Z","date":"2021-03-24","kind":"exercise","acquired":true,"shares":10930,"price":2.48,"value":27106.4,"ownership":{"direct":true},"balance_after":80792,"source":{"system":"sec-edgar","filing":"0000899243-21-013331","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924321013331/doc4.xml","form_type":"4"}},{"id":2848799,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2021-02-19T00:09:26.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests as to 50% of the shares on February 15, 2022 and 50% on February 15, 2023."}],"balance_after":50000,"derivative":{"exercise_price":10.48,"expiration_date":"2031-02-01","underlying":"Ordinary Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-21-007201","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924321007201/doc4.xml","form_type":"4"}},{"id":2848798,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-19T00:09:26.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":1722,"price":10.57,"value":18201.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On February 16, 2021, the reporting person sold 1,722 ordinary shares solely to cover taxes associated with the vesting of RSUs on February 15, 2021. These sales were made pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $10.50 to $10.58 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":69862,"source":{"system":"sec-edgar","filing":"0000899243-21-007201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924321007201/doc4.xml","form_type":"4"}},{"id":2848797,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":66858,"kind":"person","name":"Moran Kyle","position":1,"cik":"0001657765","reported_name":"Moran Kyle","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-19T00:09:26.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted share units (RSUs). The RSUs vest in two equal installments on February 15, 2022 and February 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,500 ordinary shares acquired under the issuer's 2019 Employee Share Purchase Plan (ESPP) on January 14, 2021."}],"balance_after":71584,"source":{"system":"sec-edgar","filing":"0000899243-21-007201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924321007201/doc4.xml","form_type":"4"}}]}